HiberGene Closes €1.5M Series B Tranche | GenomeWeb

NEW YORK (GenomeWeb) – HiberGene Diagnostics has raised a first tranche of €1.5 million ($1.6 million) as part of a planned series B fundraising round of approximately €3.5 million, the Dublin-based molecular diagnostics firm said today.

The first tranche comes from a number of undisclosed private investors in Ireland, and was facilitated primarily through the Irish Employment and Investment Incentive scheme, which provides tax relief to investors who back small- and medium-sized companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.